 GERMANTOWN, Md., March 22, 2021 PRNewswire -- Seneca Biopharma, Inc. Nasdaq: SNCA, a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today reported its financial results for the year ended December 31, 2020. 